Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?

Схожие документы

• Role of concomitant therapy for Helicobacter pylori eradication: A technical note
  по: Losurdo, Giuseppe, et al.
  Опубликовано: (2016)
• Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
  по: Ierardi, Enzo, et al.
  Опубликовано: (2017)
• A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
  по: Losurdo, Giuseppe, et al.
  Опубликовано: (2016)
• Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study
  по: Mori, Hideki, et al.
  Опубликовано: (2015)
• How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?
  по: Ierardi, Enzo, et al.
  Опубликовано: (2013)